Too Costly & Too Scarce
Ewen, M.A.
2016
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
Ewen, M. A. (2016). Too Costly & Too Scarce: Price, availability and affordability of medicines in low- and middle-income countries.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
ϴϵ
5
countries. Several studies included assessments of the availability of medicines for acute ǀĞƌƐƵƐĐŚƌŽŶŝĐĐŽŶĚŝƟŽŶƐ;ϴͿ, cardiovascular medicines in developing countries ;ϵͿ͕ĂŶƟͲ ĞƉŝůĞƉƟĐƐŝŶĂŵďŝĂ;ϭϬͿĂŶĚŝŶ>ĂŽƐ;ϭϭͿ͕ĂŶĚĂŶƟͲĚŝĂďĞƟĐŵĞĚŝĐŝŶĞƐŝŶƚŚĞWŚŝůŝƉƉŝŶĞƐ͘;ϭϮͿ͘^ŝŵŝůĂƌĐŽŶĐůƵƐŝŽŶƐǁĞƌĞĚƌĂǁŶŝŶƚŚĞƐĞƐƚƵĚŝĞƐ͕ŶĂŵĞůLJƚŚĂƚƚŚĞŽǀĞƌĂůůĂǀĂŝůĂďŝůŝƚLJ ŽĨ ǁŝĚĞůLJ ƵƐĞĚ ŵĞĚŝĐŝŶĞƐ ŝŶĐůƵĚŝŶŐ ŐĞŶĞƌŝĐƐ ǁĂƐ ƐƵďŽƉƟŵĂů͕ ƉĂƌƟĐƵůĂƌůLJ ŝŶ ƚŚĞ ƉƵďůŝĐ ƐĞĐƚŽƌ͘ /Ŷ ĐŽŶƚƌĂƐƚ͕ ƐŽŵĞ ƐƚƵĚŝĞƐ ƐŚŽǁĞĚ ĂĚĞƋƵĂƚĞ ŵĞĚŝĐŝŶĞƐ͛ ĂǀĂŝůĂďŝůŝƚLJ͘ ^ƚƵĚŝĞƐ ŽŶ standardized lists of commonly used medicines in Sudan ;ϭϯͿĂŶĚƵƌŬŝŶĂ&ĂƐŽ;ϭϰͿƐŚŽǁĞĚ ĂƐĂƟƐĨĂĐƚŽƌLJůĞǀĞůŽĨŶĞĂƌůLJϴϬйĂǀĂŝůĂďŝůŝƚLJŽĨƚŚĞƐƵƌǀĞLJĞĚŵĞĚŝĐŝŶĞƐ͘
EŽŶĞŽĨƚŚĞƐĞƐƚƵĚŝĞƐĨŽĐƵƐĞĚĞdžĐůƵƐŝǀĞůLJŽŶĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐ͘dŚĞĨŽůůŽǁŝŶŐƐƚƵĚŝĞƐ ŵĂLJƉƌŽǀŝĚĞĂŶŝŶƐŝŐŚƚŽŶƚŚĞĞdžƚĞŶƚŽĨĂǀĂŝůĂďŝůŝƚLJŽĨŵĞĚŝĐŝŶĞƐŝŶĐůƵĚĞĚŝŶŶĂƟŽŶĂůD>Ɛ ŝŶĚŝīĞƌĞŶƚĐŽƵŶƚƌŝĞƐ͘ďŽǀĞϳϱйĂǀĞƌĂŐĞĂǀĂŝůĂďŝůŝƚLJŽĨŐĞŶĞƌŝĐŵĞĚŝĐŝŶĞƐǁĂƐƌĞƉŽƌƚĞĚ ŝŶĂŶĂƟŽŶĂůƐƵƌǀĞLJŽĨĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐŝŶƚŚĞƉƌŝǀĂƚĞƐĞĐƚŽƌŝŶ^ƌŝ>ĂŶŬĂ;ϭϱͿ and in the public sector and popular pharmacies in Brazil ;ϭϲͿ͕ĂƐǁĞůůĂƐŝŶƉƌŽǀŝŶĐŝĂůƐƵƌǀĞLJƐŽŶ ĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐŝŶƚŚŝŽƉŝĂ;ϭϳͿ͕ƉƌŝŵĂƌLJŚĞĂůƚŚĐĂƌĞĐĞŶƚĞƌƐ͛ĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐŝŶ /ŶĚŝĂ;ϭϴͿ͕ĂŶĚƚŚĞĐŚŝůĚƌĞŶ͛ƐŶĂƟŽŶĂůƌƵƌĂůŚĞĂůƚŚŵŝƐƐŝŽŶůŝƐƚŝŶƚŚĞƉƵďůŝĐƐĞĐƚŽƌŝŶ/ŶĚŝĂ ;ϭϵͿ͘ŽŶǀĞƌƐĞůLJ͕ĂŶĂƟŽŶĂůƐƚƵĚLJŽŶƚŚĞĂǀĂŝůĂďŝůŝƚLJŽĨƉĞĚŝĂƚƌŝĐĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐŝŶ^ƌŝ >ĂŶŬĂ͛ƐƉƵďůŝĐƐĞĐƚŽƌ;ϮϬͿĂƐǁĞůůĂƐƉƌŽǀŝŶĐŝĂůƐƵƌǀĞLJƐŽŶŶĂƟŽŶĂůĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐŝŶ China ;Ϯϭ͕ϮϮͿĂůůƉŽŝŶƚĞĚƚŽŝŶĂĚĞƋƵĂƚĞĂǀĂŝůĂďŝůŝƚLJŽĨƚŚĞĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐƐƚƵĚŝĞĚ͘ /ŶǀŝĞǁŽĨƚŚĞůŝŵŝƚĞĚŶƵŵďĞƌŽĨƐƚƵĚŝĞƐƚŽĚĂƚĞ͕ŶŽĞdžƚĞŶƐŝǀĞĐŽŶĐůƵƐŝŽŶƐĐĂŶďĞĚƌĂǁŶ ŽŶ ǁŚĞƚŚĞƌ ĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ ĂƌĞ ĂĚĞƋƵĂƚĞůLJ ĂǀĂŝůĂďůĞ ĂƐ Ă ƌĞƐƵůƚ ŽĨ ŐůŽďĂů ĞīŽƌƚƐ ƚŽ ŝŵƉůĞŵĞŶƚ ĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ ƉŽůŝĐŝĞƐ͘ dŚĞƌĞĨŽƌĞ͕ ƚŚŝƐ ŝŶƚĞƌŶĂƟŽŶĂů ƐƚƵĚLJ ǁĂƐ ƵŶĚĞƌƚĂŬĞŶ ƚŽ ĂƐƐĞƐƐ ĚŝīĞƌĞŶĐĞƐ ŝŶ ƚŚĞ ĂǀĂŝůĂďŝůŝƚLJ ŽĨ ĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ ĐŽŵƉĂƌĞĚ ƚŽ ŵĞĚŝĐŝŶĞƐ ǁŚŝĐŚ ĂƌĞ ŶŽƚ ŽŶ D>Ɛ ;ŚĞƌĞĂŌĞƌ ĐĂůůĞĚ ͞ŶŽŶͲĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ͟Ϳ ŝŶ ďŽƚŚ public and private sectors.
Dd,K^
ĂƚĂƐŽƵƌĐĞ
ϵϬ
ĐŽŶĚƵĐƚĞĚŝŶĐŽŵƉůŝĂŶĐĞǁŝƚŚĂƐƚĂŶĚĂƌĚŵĞƚŚŽĚŽůŽŐLJĚĞǀĞůŽƉĞĚďLJt,Kͬ,/;Ϯϰ͕ϮϱͿ. The survey medicines comprised a core list and a supplementary list of medicines. The ĐŽƌĞůŝƐƚǁĂƐƐĞůĞĐƚĞĚĨƌŽŵŵĞĚŝĐŝŶĞƐŝŶĚŝĐĂƚĞĚĨŽƌĐŽŵŵŽŶĐŚƌŽŶŝĐŽƌĂĐƵƚĞĐŽŶĚŝƟŽŶƐŝŶ global and regional scales. The supplementary list included medicines selected at country ůĞǀĞůďĂƐĞĚŽŶƚŚĞŝƌůŽĐĂůŝŵƉŽƌƚĂŶĐĞĨŽƌŶĂƟŽŶĂůŚĞĂůƚŚĐĂƌĞƐLJƐƚĞŵƐ͘WƌĂĐƟĐĂůĚĞƚĂŝůƐ ŽĨƚŚĞƐƵƌǀĞLJƐĂƐǁĞůůĂƐƚŚĞǀĂůŝĚĂƟŽŶŵĞƚŚŽĚŚĂǀĞďĞĞŶĞdžƉůĂŝŶĞĚĞůƐĞǁŚĞƌĞ;ϳ͕Ϯϯ͕ϮϲͿ. ƐĂƐĞĐŽŶĚƐƚĞƉ͕ĂůůŶĂƟŽŶĂůD>ƐǁĞƌĞŽďƚĂŝŶĞĚĨƌŽŵƚŚĞt,KĚĂƚĂďĂƐĞŽĨĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞůŝƐƚƐĂŶĚĨŽƌŵƵůĂƌŝĞƐǁŚŝĐŚŝƐĨƌĞĞůLJĂĐĐĞƐƐŝďůĞŽŶƚŚĞǁĞď;ϮϳͿ. ^ƚƵĚLJŝŶĐůƵƐŝŽŶ ůů ƐƵƌǀĞLJƐ ŝŶĐůƵĚĞĚ ŝŶ ƚŚĞ t,Kͬ,/ ĚĂƚĂďĂƐĞ ŽŶ ϭϱ Ɖƌŝů ϮϬϭϮ ǁĞƌĞ ŝŶĐůƵĚĞĚ ŝŶ ŽƵƌ ƐƚƵĚLJĞdžĐĞƉƚ;ĂͿƚŚŽƐĞĨŽƌǁŚŝĐŚƚŚĞŶĂƟŽŶĂůD>͕ĐƵƌƌĞŶƚĂƚƚŚĞƟŵĞŽĨƚŚĞƐƵƌǀĞLJ͕ǁĂƐ ŶŽƚĂǀĂŝůĂďůĞ͕ĂŶĚ;ďͿĞŝŐŚƚƉŝůŽƚƐƵƌǀĞLJƐǁŚĞƌĞĂǀĂŝůĂďŝůŝƚLJǁĂƐĂƐƐĞƐƐĞĚƵƐŝŶŐĂĚŝīĞƌĞŶƚ ŵĞƚŚŽĚŽůŽŐLJ͘tŚĞƌĞŵƵůƟƉůĞƐƵƌǀĞLJƐǁĞƌĞĐŽŶĚƵĐƚĞĚŝŶĂĐŽƵŶƚƌLJ͕ĂǀĞƌĂŐĞĂǀĂŝůĂďŝůŝƚLJ ǁĂƐĐĂůĐƵůĂƚĞĚǁŝƚŚŽƵƚǁĞŝŐŚƟŶŐ͘dĂďůĞϭůŝƐƚƐƚŚĞϮϯĐŽƵŶƚƌŝĞƐ;ϮϴƐƵƌǀĞLJƐͿŝŶĐůƵĚĞĚŝŶ the study. ĂƚĂĂŶĂůLJƐŝƐ ĂƚĂ ǁĞƌĞ ĂŶĂůLJnjĞĚ Ăƚ Ă ŐůŽďĂů ƐĐĂůĞ ĮƌƐƚ͘ WŽŽůĞĚ ĚĂƚĂ ŽĨ ƚŚĞ ƐƚƵĚŝĞĚ ŵĞĚŝĐŝŶĞƐ ǁĞƌĞ ĂƐƐŝŐŶĞĚ ƚŽ ĞŝƚŚĞƌ ĞƐƐĞŶƟĂů Žƌ ŶŽŶͲĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ͕ ďĂƐĞĚ ŽŶ ƚŚĞ ŶĂƟŽŶĂů D> Ăƚ ƚŚĞƟŵĞŽĨƚŚĞƐƵƌǀĞLJ͘ǀĂŝůĂďŝůŝƚLJǁĂƐĐĂůĐƵůĂƚĞĚĂƐƚŚĞƉĞƌĐĞŶƚĂŐĞŽĨŵĞĚŝĐŝŶĞŽƵƚůĞƚƐ ƐƵƌǀĞLJĞĚǁŚĞƌĞƚŚĞŵĞĚŝĐŝŶĞǁĂƐĂǀĂŝůĂďůĞŽŶƚŚĞĚĂLJŽĨĚĂƚĂĐŽůůĞĐƟŽŶ͘/ŶĂĚĚŝƟŽŶƚŽ studying the availability of originator brands and generic equivalents, the availability of ĂŶLJƉƌŽĚƵĐƚƚLJƉĞ;ŽƌŝŐŝŶĂƚŽƌďƌĂŶĚŽƌŐĞŶĞƌŝĐĐŽŵďŝŶĞĚ͕ƐĞĞdĂďůĞϮĨŽƌĚĞĮŶŝƟŽŶƐͿǁĂƐ assessed to determine the overall availability of each medicine.
dŚĞŵĞĚŝĂŶĂǀĂŝůĂďŝůŝƚLJŽĨŽƌŝŐŝŶĂƚŽƌďƌĂŶĚƐ͕ŐĞŶĞƌŝĐƐĂŶĚĂŶLJƉƌŽĚƵĐƚƚLJƉĞǁĂƐĐĂůĐƵůĂƚĞĚ ĂŶĚĐŽŵƉĂƌĞĚĨŽƌĞƐƐĞŶƟĂůĂŶĚŶŽŶͲĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐ͕ĂĐƌŽƐƐĂůůƐĞĐƚŽƌƐĂŶĚŝŶĚŝǀŝĚƵĂů ƐĞĐƚŽƌƐ;ƉƵďůŝĐ͕ƉƌŝǀĂƚĞͿ͘
ϵϭ
5
dĂ
ďůĞϭ͗
Coun
tries and sur
ϵϮ EŽŶͲƉĂƌĂŵĞƚƌŝĐƌĂŶŬƚĞƐƚƐƉĞƌĨŽƌŵĞĚǁĞƌĞ;ϭͿƚŚĞDĂŶŶͲtŚŝƚŶĞLJhƚĞƐƚƚŽĐŽŵƉĂƌĞƚŚĞ ĂǀĂŝůĂďŝůŝƚLJ ŽĨ ĞƐƐĞŶƟĂů ǀĞƌƐƵƐ ŶŽŶͲĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ ǁŚĞŶ ŚŽŵŽŐĞŶĞŝƚLJ ŽĨ ǀĂƌŝĂŶĐĞƐ ǁĂƐĞƐƚĂďůŝƐŚĞĚ͕;ϮͿƚŚĞDŽŽĚƐŵĞĚŝĂŶƚĞƐƚƚŽĐŽŵƉĂƌĞĂǀĂŝůĂďŝůŝƚLJŽĨĞƐƐĞŶƟĂůǀĞƌƐƵƐŶŽŶͲ ĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐǁŚĞŶŚŽŵŽŐĞŶĞŝƚLJŽĨǀĂƌŝĂŶĐĞƐǁĂƐŶŽƚĂƐƐƵŵĞĚ͕ĂŶĚ;ϯͿĂ<ƌƵƐŬĂůͲ tĂůůŝƐ ŽŶĞͲǁĂLJ ĂŶĂůLJƐŝƐ ŽĨ ǀĂƌŝĂŶĐĞ ďLJ ƌĂŶŬƐ ĨŽƌ ĐŽŵƉĂƌŝŶŐ ĂĐƌŽƐƐ tŽƌůĚ ĂŶŬ ŝŶĐŽŵĞ ŐƌŽƵƉƐŝŶƚĞƌŵƐŽĨƚŚĞĂǀĂŝůĂďŝůŝƚLJŽĨĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐ͘dŽĂƐƐĞƐƐŝĨƚŚĞĂǀĂŝůĂďŝůŝƚLJŐĂƉ ŽĨ ĞƐƐĞŶƟĂů ĂŶĚ ŶŽŶͲĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ ŝƐ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ ƚŚĞ 'ŝŶŝ ĐŽĞĸĐŝĞŶƚ͕ ůŝŶĞĂƌ ƌĞŐƌĞƐƐŝŽŶĂŶĂůLJƐŝƐǁĂƐĞdžĂŵŝŶĞĚ͘ƉсǀĂůƵĞƐŵĂůůĞƌƚŚĂŶϬ͘ϬϱǁĂƐĐŽŶƐŝĚĞƌĞĚƐŝŐŶŝĮĐĂŶƚ for all the tests.
ϵϯ
5
ŵĞĚŝĐŝŶĞƐ ǁĂƐ Ϯϳ͘ϯй͘ dŚŝƐ ĚŝīĞƌĞŶĐĞ ŝŶ ĂǀĂŝůĂďŝůŝƚLJ ǁĂƐ ĚƌŝǀĞŶ ďLJ ŐĞŶĞƌŝĐ ŵĞĚŝĐŝŶĞƐ͖ ƚŚĞŵĞĚŝĂŶĂǀĂŝůĂďŝůŝƚLJŽĨŐĞŶĞƌŝĐĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐǁĂƐϱϯ͘ϯйǀĞƌƐƵƐϭϵ͘ϮйĨŽƌŶŽŶͲ ĞƐƐĞŶƟĂůŐĞŶĞƌŝĐƐ͘dŚĞŽǀĞƌĂůůŵĞĚŝĂŶĂǀĂŝůĂďŝůŝƚLJŽĨŽƌŝŐŝŶĂƚŽƌďƌĂŶĚƐǁĂƐϬй͕ǁŝƚŚŶŽ ƐŝŐŶŝĮĐĂŶƚ ĚŝīĞƌĞŶĐĞ ďĞƚǁĞĞŶ ĞƐƐĞŶƟĂů ;/YZ Ϭйശϭϴ͘ϰйͿ ĂŶĚ ŶŽŶͲĞƐƐĞŶƟĂů ŵĞĚŝĐŝŶĞƐ ;/YZϬйശϮϭ͘ϭйͿ;ƉсϬ͘ϱϳϵͿ͘^ŝŵŝůĂƌƉĂƩĞƌŶƐǁĞƌĞŽďƐĞƌǀĞĚŝŶĞĂĐŚƐĞĐƚŽƌ͘dĂďůĞϯ͗Median availability of surveyed medicines
ϵϳ
ϵϵ